Changes in Treatment Patterns and Overall Survival for Early-Stage Diffuse Large B Cell Lymphoma in the United States After Rituximab: A Population-Based Analysis

被引：0
|
作者：
Haque, W. [1 ]
Tann, A. W. J. [2 ]
Szeja, S. [3 ]
Butler, E. B. [4 ]
Teh, B. S. [5 ]
机构：
[1] Greater Houston Phys Med Assoc, Houston, TX USA
[2] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Galveston, TX 77555 USA
[4] Houston Methodist Hosp, Weil Cornell Med Coll, Houston, TX USA
[5] Houston Methodist Hosp, Houston, TX USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.420
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1007
引用
收藏
页码：S167 / S167
页数：1
相关论文
共 50 条
  • [31] Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
    Vargo, John A.
    Gill, Beant S.
    Balasubramani, Goundappa K.
    Beriwal, Sushil
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3710 - +
  • [32] Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis
    Khor, Sara
    Beca, Jaclyn
    Krahn, Murray
    Hodgson, David
    Lee, Linda
    Crump, Michael
    Bremner, Karen E.
    Luo, Jin
    Mamdani, Muhammad
    Bell, Chaim M.
    Sawka, Carol
    Gavura, Scott
    Sullivan, Terrence
    Trudeau, Maureen
    Peacock, Stuart
    Hoch, Jeffrey S.
    BMC CANCER, 2014, 14
  • [33] Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis
    Sara Khor
    Jaclyn Beca
    Murray Krahn
    David Hodgson
    Linda Lee
    Michael Crump
    Karen E Bremner
    Jin Luo
    Muhammad Mamdani
    Chaim M Bell
    Carol Sawka
    Scott Gavura
    Terrence Sullivan
    Maureen Trudeau
    Stuart Peacock
    Jeffrey S Hoch
    BMC Cancer, 14
  • [34] Primary Diffuse Large B-Cell Lymphoma of the Urinary Tract: A Population-Based Analysis
    Liu, Zheng-Huan
    Yang, Lu-Chen
    Song, Pan
    Fang, Kun
    Zhou, Jing
    Peng, Zhu-Feng
    Dong, Qiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma
    Changhoon Yoo
    Dok Hyun Yoon
    Jeong Eun Kim
    Jungmin Jo
    Seong Joon Park
    Shin-Kyo Yoon
    Yongchel Ahn
    Shin Kim
    Jooryung Huh
    Dae Ho Lee
    Cheolwon Suh
    International Journal of Hematology, 2013, 97 : 232 - 239
  • [36] Rituximab Does Not Improve Progression Free (PFS) or Overall Survival (OS) in Patients with Limited Stage Diffuse Large B Cell Lymphoma (DLBCL)
    Hochberg, Ephraim P.
    Birrer, Nicole
    Toomey, Christiana E.
    Barnes, Jeffrey A.
    Lee, Alfred Ian
    LaCasce, Ann
    Abramson, Jeremy S.
    BLOOD, 2009, 114 (22) : 1445 - 1446
  • [37] Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma
    Yoo, Changhoon
    Yoon, Dok Hyun
    Kim, Jeong Eun
    Jo, Jungmin
    Park, Seong Joon
    Yoon, Shin-Kyo
    Ahn, Yongchel
    Kim, Shin
    Huh, Jooryung
    Lee, Dae Ho
    Suh, Cheolwon
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 232 - 239
  • [38] Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy
    Parikh, Rahul R.
    Yahalom, Joachim
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 614 - 622
  • [39] Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study
    Hang, Haifang
    Zhou, Hui
    Ma, Liyuan
    MEDICINE, 2024, 103 (08) : E37238
  • [40] Primary mediastinal/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival
    Huijie Zhou
    Qiuluo Liu
    Siyan Lu
    Liqun Zou
    Annals of Hematology, 2023, 102 : 1879 - 1886
12345